AQST Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $4.55

Piyasa Değeri (MRQ) $571M

P/E (TTM) -7.0

Hisse Başına Kâr (TTM) $-0.65

Gelir (TTM) $54M

ROE (TTM) 121.1%

52 Haftlık Aralık $3–$8

AQST Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$45M

2017-12-31 → 2025-12-31

Hisse Başına Kâr$-0.78

2020-12-31 → 2025-12-31

Serbest Nakit Akışı$-53M

2018-12-31 → 2025-12-31

Net kar marjı-144.6%

2018-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	AQST	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-7.05Y ort. ≈-6.7	≈-6.7	·	·
F/S (TTM)	10.65Y ort. ≈6.1	≈6.1	4.9	Aşırı değerli
F/D (MRQ)	-10.15Y ort. ≈-6.5	≈-6.5	·	·
Fiyat / Serbest Nakit Akışı (TTM)	-12.45Y ort. ≈-10.4	≈-10.4	·	·
Fiyat / Nakit Akışı (TTM)	-12.65Y ort. ≈-11.2	≈-11.2	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	AQST	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-97.5%5Y ort. ≈-79.9%	≈-79.9%	-1.8%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-159.5%5Y ort. ≈-79.9%	≈-79.9%	1.8%	Zayıf
Vergi Öncesi Kar Marjı (TTM)	-144.6%5Y ort. ≈-106.5%	≈-106.5%	12.8%	Zayıf
Net Kâr Marjı (TTM)	-144.6%5Y ort. ≈-106.6%	≈-106.6%	-7.5%	Zayıf
ROA (TTM)	-69.3%5Y ort. ≈-67.5%	≈-67.5%	-14.9%	Zayıf
ROE (TTM)	121.1%5Y ort. ≈79.2%	≈79.2%	37.8%	En üst düzey
ROIC	211.1%5Y ort. ≈70.9%	≈70.9%	7.1%	En üst düzey

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	AQST	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		7.25Y ort. ≈2.6	≈2.6	4.3	Güçlü likidite
Quick Ratio (Cari Oran)		0.4	·	2.6	Güçlü likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	AQST	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	-22.6%5Y ort. ≈0.39%	≈0.39%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	-2.2%5Y ort. ≈1.8%	≈1.8%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	-0.58%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	AQST	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-0.785Y ort. ≈$-0.88	≈$-0.88	·	·
Revenue / Share (Hisse Başına Gelir)	$0.425Y ort. ≈$0.84	≈$0.84	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-0.495Y ort. ≈$-0.41	≈$-0.41	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	AQST	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.35Y ort. ≈0.7	≈0.7	0.4	Aynı seviyede
Inventory Turnover (Stok Devir Hızı)	3.05Y ort. ≈3.0	≈3.0	1.2	En üst düzey
Receivables Turnover (Alacak Devir Hızı)	3.5	·	3.5	Zayıf
Revenue / Employee (Çalışan Başına Gelir)	≈$303.0K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 6.6%

Sonraki Rapor Kas 03, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 11, 2026	$-0.08	$-0.11	24.1%
31 Mart 2026	May 13, 2026	$-0.07	$-0.14	50.0%
31 Aralık 2025		$-0.15	$-0.14	-10.9%
30 Eylül 2025		$-0.14	$-0.14	-3.6%
30 Haziran 2025		$-0.14	$-0.17	18.5%
31 Mart 2025		$-0.24	$-0.17	-38.4%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 16

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	$67M
Cost of Revenue	$19M	$18M	$21M	$19M	·	$13M	$20M	·	·
R&D Expense	$17M	$20M	$13M	$17M	$17M	$20M	$21M	$23M	$22M
SG&A Expense	$80M	$50M	$32M	$53M	$53M	$56M	$64M	$72M	$25M
Operating Expenses	$116M	$88M	$66M	$90M	$86M	$89M	$105M	$116M	$67M
Operating Income	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-49M	$-113.0K
Interest Expense	·	·	$6M	$7M	$10M	$11M	$9M	$8M	$8M
Interest Income	·	·	·	·	·	$132.0K	$636.0K	·	·
Pretax Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
Income Tax	$0	$-14.0K	$245.0K	$0	$0	$0	$0	$0	$0
Net Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
EPS (Basic)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
EPS (Diluted)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
Shares (Basic)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
Shares (Diluted)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
EBITDA	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-46M	·

Bilanço 24

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$121M	$72M	$24M	$27M	$28M	$32M	$49M	$61M	$17M
Receivables	$18M	$7M	$8M	·	·	·	·	·	$6M
Inventory	$6M	$6M	$7M	$6M	$4M	$2M	$3M	$5M	$4M
Prepaid Expense	$4M	$3M	$2M	$2M	$3M	$3M	$3M	$2M	$591.0K
Current Assets	$149M	$88M	$41M	$40M	$47M	$45M	$68M	$74M	$28M
PP&E (Net)	$4M	$4M	$4M	$4M	$5M	$7M	$10M	$12M	$13M
PP&E (Gross)	$48M	$47M	$47M	$46M	$45M	$48M	$48M	$47M	$45M
Accum. Depreciation	$44M	$44M	$43M	$42M	$40M	$41M	$38M	$35M	$32M
Intangibles	$0	$0	$1M	$1M	$51.0K	$102.0K	$153.0K	$204.0K	$254.0K
Other Non-current Assets	$3M	$4M	$5M	$6M	$7M	$8M	$286.0K	$239.0K	$1M
Total Assets	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Accounts Payable	$30M	$10M	$9M	$10M	$8M	$7M	$12M	$20M	$10M
Accrued Liabilities	$5M	$6M	$6M	$8M	$9M	$9M	$5M	$7M	$4M
Current Liabilities	$48M	$19M	$18M	$40M	$22M	$21M	$19M	$33M	$15M
Capital Leases	$4M	$5M	$5M	$5M	$2M	$3M	$0	·	·
Other Non-current Liabilities	$7M	$2M	$2M	$2M	$2M	$2M	$1M	·	·
Total Liabilities	$194M	$162M	$164M	$176M	$144M	$111M	$85M	$77M	$70M
Long-term Debt	$45M	$45M	$45M	·	·	$52M	$70M	·	·
Common Stock	$122.0K	$91.0K	$69.0K	$55.0K	$41.0K	$35.0K	$34.0K	$25.0K	$0
Paid-in Capital	$413M	$303M	$213M	$193M	$175M	$138M	$124M	$71M	$0
Retained Earnings	$-447M	$-363M	$-319M	$-311M	$-257M	$-186M	$-130M	$-61M	$-120M
Stockholders' Equity	$-34M	$-60M	$-106M	$-119M	$-82M	$-48M	$-6M	$10M	$-26M
Liabilities + Equity	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Shares Outstanding	122,044,299	91,413,742	68,533,085	54,827,734	41,228,736	34,569,254	33,562,885	24,957,309	·

Nakit Akışı 13

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$548.0K	$718.0K	$1M	$2M	$3M	$3M	$3M	$3M	$4M
Stock-based Comp	$8M	$7M	$3M	$4M	$7M	$7M	$7M	$30M	$0
Deferred Tax	$0	$0	$0	$0	·	·	·	·	·
Amort. of Intangibles	$0	$78.0K	$157.0K	$116.0K	$51.0K	$51.0K	$50.0K	$50.0K	$51.0K
Other Non-cash	·	·	·	·	·	·	·	$15M	·
Operating Cash Flow	$-52M	$-36M	$-6M	$-10M	$-33M	$-45M	$-60M	$-13M	$6M
CapEx	$562.0K	$159.0K	$995.0K	$1M	$913.0K	$517.0K	$663.0K	$2M	$2M
Investing Cash Flow	$-562.0K	$-159.0K	$-995.0K	$-3M	$-913.0K	$-517.0K	$-663.0K	$-2M	$-2M
Financing Cash Flow	$103M	$84M	$4M	$12M	$30M	$28M	$50M	$58M	$4M
Net Change in Cash	$50M	$48M	$-3M	$-751.0K	$-4M	$-18M	·	$43M	$8M
Taxes Paid	$0	$305.0K	$0	·	·	·	·	·	·
Free Cash Flow	$-53M	$-36M	$-7M	$-11M	$-34M	$-46M	$-61M	$-15M	·
Levered FCF	·	·	$-14M	$-17M	$-44M	$-57M	$-70M	$-23M	·

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-72.6%	·
Net Margin	-188.1%	-76.7%	-15.6%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
Pretax Margin	-188.1%	-76.7%	-15.1%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
EBITDA Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-67.8%	·
ROA	-64.0%	-55.6%	-13.8%	-91.4%	-113.0%	-78.9%	-80.1%	-94.5%	·
ROE	157.7%	83.6%	7.5%	48.1%	99.0%	131.2%	326.5%	-366.2%	·
ROIC	211.1%	51.1%	14.6%	35.5%	42.2%	88.4%	860.3%	-485.5%	·

Likidite ve Solventlik 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	3.1	4.7	2.2	1.0	2.2	2.1	3.7	2.3	·
Quick Ratio	0.4	0.4	·	·	·	1.5	2.7	1.8	·
Interest Coverage	·	·	-2.4	-6.4	-3.5	-3.9	-5.7	-6.3	·

Verimlilik 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.3	0.7	0.9	0.8	0.8	0.6	0.6	1.0	·
Inventory Turnover	3.0	2.8	3.3	·	·	4.9	·	·	·
Receivables Turnover	3.5	7.3	·	·	·	·	·	·	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$-0.28	$-0.66	$-1.55	$-2.16	$-1.99	$-1.40	$-0.18	$0.40	·
Revenue / Share	$0.42	$0.66	$0.83	$0.98	$1.33	·	·	·	·
Cash Flow / Share	$-0.49	$-0.41	$-0.10	$-0.20	$-0.87	·	·	·	·
Cash / Share	·	·	·	·	·	$0.92	$1.47	$2.43	·
EPS (TTM)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-22.6%	13.8%	6.1%	-6.2%	10.9%	·	·	·	·
Revenue CAGR 3Y	-2.2%	4.2%	3.3%	·	·	·	·	·	·
Revenue CAGR 5Y	-0.58%	·	·	·	·	·	·	·	·

Değerleme (TTM) 9

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	·
Net Income TTM	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	·
Market Cap	$788M	$325M	$138M	$49M	$160M	$185M	$195M	$157M	·
P/E	-8.3	-7.0	-15.5	-0.8	-2.1	-3.2	·	·	·
P/S	17.7	5.7	2.7	1.0	3.2	4.0	3.7	2.3	·
P/B	-23.4	-5.4	-1.3	-0.4	-2.0	-3.8	-31.9	15.6	·
P / Cash Flow	-15.0	-9.1	-21.7	-5.1	-4.9	-4.1	-3.2	-12.1	·
P / FCF	-14.9	-9.1	-18.8	-4.6	-4.7	-4.0	-3.2	-10.6	·
Earnings Yield	-12.1%	-14.3%	-6.4%	-124.2%	-47.6%	-31.0%	·	·	·

Gelir Tablosu 15

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$14M	$14M	$13M	$13M	$10M	$9M	$12M	$14M	$20M	$12M	$13M	$13M	$13M	$11M	$11M	$11M
Cost of Revenue	$4M	$3M	$6M	$5M	$5M	$4M	$5M	$4M	$5M	$4M	$5M	$5M	$7M	$5M	$5M	$5M
R&D Expense	$4M	$4M	$3M	$5M	$4M	$5M	$5M	$5M	$4M	$6M	$3M	$3M	$3M	$4M	$4M	$3M
SG&A Expense	$14M	$11M	$33M	$15M	$13M	$19M	$16M	$12M	$11M	$11M	$10M	$7M	$7M	$7M	$12M	$12M
Operating Expenses	$22M	$19M	$42M	$24M	$21M	$28M	$25M	$22M	$20M	$21M	$17M	$15M	$17M	$16M	$21M	$20M
Operating Income	$-8M	$-4M	$-29M	$-11M	$-11M	$-19M	$-14M	$-8M	$55.0K	$-9M	$-4M	$-2M	$-4M	$-5M	$-11M	$-9M
Interest Expense	·	·	·	·	·	·	·	·	$3M	$3M	·	$1M	$1M	$1M	$2M	$2M
Pretax Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
Income Tax	$0	$0	$0	$0	$0	$0	$-14.0K	$0	$0	$0	$101.0K	$-140.0K	$284.0K	$0	$0	$0
Net Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
EPS (Basic)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.15	$-0.03	$-0.10	$0.15	$-0.21	$-0.23
EPS (Diluted)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.11	$-0.03	$-0.10	$0.11	$-0.21	$-0.23
Shares (Basic)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	55,631,947	·	53,424,922
Shares (Diluted)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	73,792,886	·	53,424,922
EBITDA	$-8M	$-4M	·	$-11M	$-11M	$-19M	·	$-8M	$55.0K	$-9M	·	$-2M	$-4M	$-5M	·	$-9M

Bilanço 24

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$98M	$111M	·	$129M	$61M	$69M	·	$78M	$90M	$95M	·	$25M	$22M	$27M	·	$19M
Receivables	$9M	$7M	$18M	·	·	·	$7M	·	·	·	$8M	·	·	·	·	·
Inventory	$7M	$8M	$6M	$8M	$8M	$7M	$6M	$7M	$7M	$8M	$7M	$7M	$6M	$7M	$6M	$7M
Prepaid Expense	$3M	$5M	$4M	$3M	$1M	$3M	$3M	$2M	$1M	$2M	$2M	$2M	$1M	$2M	$2M	$2M
Current Assets	$118M	$130M	$149M	$152M	$82M	$89M	$88M	$97M	$104M	$113M	$41M	$42M	$40M	$44M	$40M	$38M
PP&E (Net)	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$4M	$4M	$4M
PP&E (Gross)	$48M	$48M	$48M	$48M	$48M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$46M	$46M	$46M
Accum. Depreciation	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$43M	$43M	$43M	$43M	$43M	$42M	$42M	$42M	$42M
Intangibles	·	·	$0	$0	$0	$0	$0	$0	$0	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Other Non-current Assets	$2M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M	$6M
Total Assets	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Accounts Payable	$9M	$12M	$30M	$11M	$12M	$12M	$10M	$8M	$6M	$11M	$9M	$10M	$11M	$12M	$10M	$11M
Accrued Liabilities	$5M	$3M	$5M	$5M	$5M	$3M	$6M	$5M	$6M	$5M	$6M	$5M	$4M	$5M	$8M	$8M
Current Liabilities	$16M	$32M	$48M	$26M	$23M	$18M	$19M	$15M	$14M	$18M	$18M	$24M	$39M	$40M	$40M	$37M
Capital Leases	$8M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$6M	$6M	$6M	$5M	$1M
Other Non-current Liabilities	$6M	$6M	$7M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Total Liabilities	$189M	$175M	$194M	$168M	$166M	$163M	$162M	$155M	$153M	$166M	$164M	$162M	$164M	$171M	$176M	$160M
Long-term Debt	$55M	$45M	$45M	$45M	$45M	$45M	·	$45M	$45M	$45M	·	$39M	$39M	$42M	·	$52M
Common Stock	$126.0K	$124.0K	$122.0K	$121.0K	$99.0K	$99.0K	$91.0K	$91.0K	$91.0K	$90.0K	$69.0K	$67.0K	$62.0K	$56.0K	$55.0K	$54.0K
Paid-in Capital	$421M	$421M	$413M	$411M	$327M	$325M	$303M	$301M	$299M	$296M	$213M	$208M	$202M	$194M	$193M	$191M
Retained Earnings	$-478M	$-455M	$-447M	$-415M	$-400M	$-386M	$-363M	$-346M	$-335M	$-332M	$-319M	$-311M	$-309M	$-303M	$-311M	$-299M
Stockholders' Equity	$-57M	$-34M	$-34M	$-4M	$-73M	$-61M	$-60M	$-45M	$-35M	$-36M	$-106M	$-103M	$-107M	$-109M	$-119M	$-108M
Liabilities + Equity	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Shares Outstanding	125,511,648	124,284,542	122,044,299	121,658,113	99,353,270	99,317,153	91,413,742	91,178,193	91,059,760	90,478,731	68,533,085	66,740,765	61,615,959	55,922,361	54,827,734	53,852,126

Nakit Akışı 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$136.0K	$113.0K	$130.0K	$139.0K	$140.0K	$139.0K	$147.0K	$159.0K	$205.0K	$207.0K	$467.0K	$264.0K	$289.0K	$325.0K	$397.0K	$596.0K
Stock-based Comp	$3M	$2M	$1M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$940.0K	$774.0K	$631.0K	$344.0K	$714.0K	$535.0K
Amort. of Intangibles	·	·	$0	$0	$0	$0	$0	$0	$39.0K	$39.0K	$40.0K	$39.0K	$39.0K	$39.0K	$51.0K	$39.0K
Operating Cash Flow	$-9M	$-15M	$-8M	$-13M	$-8M	$-23M	$-6M	$-12M	$-7M	$-10M	$-5M	$-2M	$-8M	$9M	$8M	$3M
CapEx	$212.0K	$52.0K	$85.0K	$235.0K	$107.0K	$135.0K	$15.0K	$80.0K	$35.0K	$29.0K	$16.0K	$151.0K	$826.0K	$2.0K	$26.0K	$217.0K
Investing Cash Flow	$-212.0K	$-52.0K	$-85.0K	$-235.0K	$-107.0K	$-135.0K	$-15.0K	$-80.0K	$-35.0K	$-29.0K	$-16.0K	$-151.0K	$-826.0K	$-2.0K	$-26.0K	$-2M
Financing Cash Flow	$-3M	$4M	$660.0K	$81M	$-100.0K	$21M	$157.0K	$-17.0K	$2M	$82M	$4M	$5M	$4M	$-9M	$234.0K	$-138.0K
Net Change in Cash	$-12M	$-10M	$-8M	$69M	$-8M	$-3M	$-6M	$-12M	$-5M	$71M	$-1M	$2M	$-4M	$-391.0K	$9M	$954.0K
Taxes Paid	·	·	$0	$0	$-2M	$2M	$0	$0	$-698.0K	$1M	$0	$0	·	·	·	·
Free Cash Flow	·	$-15M	·	·	·	$-24M	·	·	·	$-10M	·	·	·	$9M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$7M	·	·

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
Net Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-15.7%	-43.7%	72.5%	·	-109.4%
Pretax Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-16.7%	-41.6%	72.5%	·	-109.4%
EBITDA Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
ROA	-20.2%	-6.6%	·	-11.3%	-12.8%	-19.8%	·	-13.6%	-3.1%	-13.5%	·	-3.7%	-10.2%	13.7%	·	-21.4%
ROE	35.4%	17.0%	·	62.4%	25.1%	47.2%	·	15.5%	3.9%	17.6%	·	1.9%	5.7%	-8.0%	·	14.9%
ROIC	14.5%	12.3%	·	279.4%	15.7%	31.8%	·	18.2%	-0.16%	24.7%	·	2.2%	4.2%	4.2%	·	8.2%

Likidite ve Solventlik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.2	4.1	·	5.9	3.5	4.9	·	6.4	7.5	6.3	·	1.8	1.0	1.1	·	1.0
Quick Ratio	6.5	3.7	·	5.0	2.6	3.8	·	5.1	6.5	5.3	·	1.0	0.6	0.7	·	0.5
Interest Coverage	·	·	·	·	·	·	·	·	0.0	-3.2	·	-1.9	-3.1	-3.2	·	-5.4

Verimlilik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.2	0.2	0.1	·	0.2	0.2	0.2	·	0.2
Inventory Turnover	0.5	0.5	·	0.6	0.6	0.5	·	0.6	0.7	0.6	·	0.7	1.2	0.8	·	1.0
Receivables Turnover	1.7	4.2	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-0.45	$-0.27	·	$-0.03	$-0.73	$-0.61	·	$-0.50	$-0.39	$-0.40	·	$-1.54	$-1.73	$-1.95	·	$-2.00
Revenue / Share	$0.11	$0.12	·	$0.12	$0.10	$0.09	·	$0.15	$0.22	$0.16	·	$0.20	$0.23	$0.15	·	$0.21
Cash Flow / Share	·	$-0.12	·	·	·	$-0.24	·	·	·	$-0.14	·	·	·	$0.12	·	·
Cash / Share	$0.78	$0.89	·	$1.06	$0.61	$0.69	·	$0.85	$0.99	$1.05	·	$0.37	$0.36	$0.48	·	$0.35
EPS (TTM)	$-0.65	$-0.61	·	$-0.70	$-0.69	$-0.58	·	$-0.44	$-0.34	$-0.41	·	$-0.23	$-0.43	$-0.69	·	$-1.65

Değerleme (TTM) 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$50M	·	$43M	$44M	$54M	·	$59M	$58M	$52M	·	$48M	$47M	$47M	·	$48M
Net Income TTM	$-78M	$-69M	·	$-69M	$-65M	$-54M	·	$-35M	$-26M	$-29M	·	$-12M	$-23M	$-33M	·	$-71M
Market Cap	$522M	$516M	·	$680M	$329M	$288M	·	$454M	$237M	$385M	·	$102M	$102M	$64M	·	$63M
P/E	-6.4	-6.8	·	-8.0	-4.8	-5.0	·	-11.3	-7.6	-10.4	·	-6.7	-3.8	-1.7	·	-0.7
P/S	9.7	10.3	·	15.7	7.5	5.3	·	7.7	4.1	7.5	·	2.1	2.2	1.4	·	1.3
P/B	-9.2	-15.1	·	-165.5	-4.5	-4.7	·	-10.0	-6.7	-10.6	·	-1.0	-1.0	-0.6	·	-0.6
P / Cash Flow	·	-34.8	·	·	·	-12.3	·	·	·	-37.1	·	·	·	7.2	·	·
Earnings Yield	-15.6%	-14.7%	·	-12.5%	-20.8%	-20.0%	·	-8.8%	-13.1%	-9.6%	·	-15.0%	-26.1%	-60.5%	·	-141.0%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$45M	$58M	$51M	$48M	$51M
Faaliyet Kâr Marjı %	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%
Net Gelir	$-84M	$-44M	$-8M	$-54M	$-71M
Seyreltilmiş Hisse Başı Kâr	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	3.1	4.7	2.2	1.0	2.2
Cari Oran	0.4	0.4	·	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-53M	$-36M	$-7M	$-11M	$-34M

Kurumsal Sahipler (13F) 196 dosya · $337.8M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 196

Tutulan Değer $337.8M

Yeni pozisyonlar 26

Çıkan pozisyonlar 18

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
26 (-23 önceki Ç'ye göre)	18 (-29 önceki Ç'ye göre)	68 (+9 önceki Ç'ye göre)	49 (0 önceki Ç'ye göre)	-1.2M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
Bratton Capital Management, L.P.	$40.813.585	9.810.958	12,08%	Hisse senetleri
VANGUARD GROUP INC	$38.064.478	5.892.334	11,27%	Hisse senetleri
BlackRock, Inc.	$33.568.590	8.069.373	9,94%	Hisse senetleri
RTW INVESTMENTS, LP	$30.894.119	7.426.471	9,15%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$19.071.657	4.584.533	5,65%	Hisse senetleri
FEDERATED HERMES, INC.	$12.948.253	3.112.561	3,83%	Hisse senetleri
STATE STREET CORP	$12.180.563	2.928.020	3,61%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$10.913.743	2.622.888	3,23%	Hisse senetleri
SAMSARA BIOCAPITAL, LLC	$10.400.000	2.500.000	3,08%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$6.940.640	1.668.423	2,05%	Hisse senetleri
Sio Capital Management, LLC	$6.182.488	1.486.175	1,83%	Hisse senetleri
Propel Bio Management, LLC	$6.000.372	1.442.397	1,78%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$5.329.904	1.281.227	1,58%	Hisse senetleri
Nuveen, LLC	$5.055.336	1.215.225	1,50%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$4.530.394	1.089.037	1,34%	Hisse senetleri
COMMONWEALTH EQUITY SERVICES, LLC	$4.352.090	1.046.175	1,29%	Hisse senetleri
BARCLAYS PLC	$4.146.126	996.665	1,23%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.951.168	949.800	1,17%	Alım opsiyonu
Blue Owl Capital Holdings LP	$3.922.597	942.932	1,16%	Hisse senetleri
WASATCH ADVISORS LP	$3.645.011	878.316	1,08%	Hisse senetleri
NORTHERN TRUST CORP	$3.457.589	831.151	1,02%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$3.305.902	794.688	0,98%	Hisse senetleri
Balyasny Asset Management L.P.	$3.097.270	744.536	0,92%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.054.459	734.245	0,90%	Hisse senetleri
MORGAN STANLEY	$2.739.848	658.617	0,81%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$2.709.038	651.211	0,80%	Hisse senetleri
DAFNA Capital Management LLC	$2.687.006	645.915	0,80%	Hisse senetleri
Everstar Asset Management, LLC	$2.545.683	611.943	0,75%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$2.147.304	332.400	0,64%	Hisse senetleri
AWM Investment Company, Inc.	$1.977.664	475.400	0,59%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$1.949.247	468.569	0,58%	Hisse senetleri
Bracebridge Capital, LLC	$1.910.339	459.216	0,57%	Hisse senetleri
UBS Group AG	$1.907.002	458.414	0,56%	Hisse senetleri
CITADEL ADVISORS LLC	$1.881.140	452.197	0,56%	Hisse senetleri
JANE STREET GROUP, LLC	$1.819.958	437.490	0,54%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$1.731.592	416.248	0,51%	Hisse senetleri
STIFEL FINANCIAL CORP	$1.505.516	361.903	0,45%	Hisse senetleri
Man Group plc	$1.463.072	351.700	0,43%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.286.272	309.200	0,38%	Satım opsiyonu
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.274.599	306.394	0,38%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$1.254.852	301.647	0,37%	Hisse senetleri
MARSHALL WACE, LLP	$1.188.340	285.659	0,35%	Hisse senetleri
Walleye Capital LLC	$1.175.483	282.568	0,35%	Hisse senetleri
Simplify Asset Management Inc.	$1.159.488	278.723	0,34%	Hisse senetleri
Bank of New York Mellon Corp	$1.146.264	275.544	0,34%	Hisse senetleri
Russell Investments Group, Ltd.	$1.083.599	260.481	0,32%	Hisse senetleri
Rosalind Advisors, Inc.	$1.040.000	250.000	0,31%	Hisse senetleri
Latash Investments, LLC	$1.011.437	243.134	0,30%	Hisse senetleri
Hudson Bay Capital Management LP	$973.440	234.000	0,29%	Hisse senetleri
Lido Advisors, LLC	$895.715	215.316	0,27%	Hisse senetleri

Tüm 196 kurumsal sahibi göster →

Şirket yöneticileri 29 içeriden öğrenenler · 19 yöneticiler · 11 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Daniel Barber	President and CEO	15 Eylül 2026 S	652.317	7	$-1.220.735
Keith J Kendall	CEO and President	10 Mart 2022 A	1.000	0	$0
Ernest A Toth JR	Chief Financial Officer	05 Mayıs 2026 F	283.460	1	$-242.919
John T. Maxwell	SVP-Chief Financial Officer	18 Ağustos 2020 S	150.614	0	$0
Cassie Jung	Chief Operating Officer	03 Eylül 2026 X	206.833	2	$-664.649
Sherry Korczynski	Chief Commercial Officer	09 Eylül 2026 M	235.689	2	$-111.315
Peter E. Boyd	Chief People Officer	09 Eylül 2026 X	284.024	2	$-194.324
Thomas A. Zalewski	Chief Legal Officer	18 Mayıs 2026 A	100.000	0	$0
Melina Cioffi	SVP, Regulatory Affairs	15 Mayıs 2026 F	273.200	1	$-105.547
Lori J Braender	Corporate Secretary	07 Mayıs 2026 F	231.042	1	$-167.225
Matthew J. Greenhawt	Chief Medical Officer	09 Mart 2026 A	75.000	0	$0
Matthew W. Davis	Chief Development Officer	09 Mart 2026 A	100.000	0	$0
Carl N Kraus	Chief Medical Officer	15 Ekim 2025 S	282.475	1	$-141.904
Stephen Wargacki	Chief Science Officer	07 Mart 2025 A	343.552	0	$0
Alexander Mark Schobel	Chief Innovation/Tech Officer	09 Mart 2024 F	980.726	0	$0
Ken W. Marshall	SVP, Chief Commercial Officer	09 Ağustos 2023 A	150.000	0	$0
Kenneth Truitt	Chief Medical Officer	06 Eylül 2022 A	·	0	$0
Theresa Wood	SVP-HR and Org. Development	10 Mart 2022 A	80.765	0	$0
Gary H Slatko	SVP, Chief Medical Officer	16 Mart 2020 A	·	0	$0
Julie Krop	Yönetim kurulu üyesi	23 Haziran 2026 M	0	1	$-125.500
Abigail L. Jenkins	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
Marco Taglietti	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
John Cochran	Yönetim kurulu üyesi	10 Haziran 2026 A	99.486	0	$0
Gregory B Brown	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
Timothy E Morris	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
COSTA SANTO J	Yönetim kurulu üyesi	20 Haziran 2024 A	·	0	$0
Nancy Lurker	Yönetim kurulu üyesi	15 Haziran 2021 A	·	0	$0
James S Scibetta	Yönetim kurulu üyesi	15 Haziran 2021 A	31.635	0	$0
Douglas K Bratton	10% sahip	02 Aralık 2024 G	199.841	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 16 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
PILL · Direxion Shares ETF Trust	0,51%	28.299 NS	31 Temmuz 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,45%	23.471 SH	02 Ekim 2026	Günlük
IWC · iShares Trust	0,13%	367.240 SH	11 Eylül 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	8.980 SH	02 Ekim 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,02%	59.348 SH	19 Ağustos 2026	Günlük
IWM · iShares Trust	0,02%	2.767.037 SH	11 Eylül 2026	Günlük
IWO · iShares Trust	0,01%	374.338 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,01%	51.582 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	621.390 SH	19 Ağustos 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	43.284 SH	19 Ağustos 2026	Günlük
ITOT · iShares Trust	0,00%	165.523 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,00%	34.314 SH	11 Eylül 2026	Günlük
VXF · VANGUARD INDEX FUNDS	0,00%	1.077.349 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	3.403.709 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	10.223 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	638.760 SH	11 Eylül 2026	Günlük

AQST Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 15 analist AL

Medyan hedef $10.00 +119,8%

4 26,7% Güçlü Al

10 66,7% Al

1 6,7% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

9 analist · 2026-09-27

Ortalama hedef $9.33 +105,1%

← Tüm hedeflerin altında Mevcut fiyat $4.55

Düşük$6.00 Ortalama$9.33 Yüksek$11.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
AQST	$788M	-8.3	-22.6%	-188.1%	157.7%	·
COLL	$1.47B	26.8	23.6%	8.1%	23.5%	59.4%
ACRS	$363M	-5.7	-58.2%	-829.6%	-55.3%	·
CRMD	$922M	5.7	617.0%	52.3%	52.1%	88.5%
ZVRA	$509M	6.6	350.9%	78.2%	61.2%	·
PHAT	$1.18B	-5.5	216.9%	-126.4%	52.4%	87.1%
EOLS	$432M	-8.3	11.6%	-17.4%	247.3%	66.3%
CTNM	·	-5.3	·	·	-27.7%	·
ARVN	$753M	-10.4	-0.30%	-30.8%	-15.5%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

AQST Aquestive Therapeutics, Inc. - Common Stock